Stockreport

Novartis to pay Monte Rosa $150 million upfront to develop a new class of drugs [Yahoo! Finance]

Novartis AG  (NVS) 
Last novartis ag earnings: 4/28 01:00 am Check Earnings Report
US:NYSE Investor Relations: novartis.com/investors
PDF The agreement covers a class of drugs called "molecular glue degraders," which target abnormal protein functions associated with some diseases that are hard to treat wi [Read more]